We are in the starting blocks to attend COMPAMED 2023 – one of the world’s most prestigious medical technology trade shows. This show is invaluable to us as it gives us the opportunity to experience first-hand the latest technological developments and innovations in our industry.
CompAMED functions not only as a showcase for technologies, but also as a platform for intensive professional exchange. We eagerly look forward to this opportunity to share our insights and explore potential collaborations with leading companies and professionals.
Our dedicated experts will be on hand during the show to identify groundbreaking solutions and products that can enrich our ongoing projects. Our top priority is to keep our finger on the pulse to provide world-class services and products to our customers.
We invite you to contact us to arrange a personal meeting and learn more about our innovations and services. Take this chance to explore common opportunities and discuss our cooperation. We are highly motivated to understand your needs and offer customized solutions.
Contact us today at mail@velixx.com, and we look forward to meeting you in person at COMPAMED 2023 from 13.11.2023 to 16.11.2023.
Our booth at MedtecLIVE with T4M in Nuremberg was a great success and an excellent opportunity for interesting discussions and inspiring new ideas.
Of course, anyone who was unable to visit us at our booth in person missed out. But we all know the challenges that can come with limited time and busy calendars. Sometimes you just can’t get everything done that you set out to do.
But luckily, you don’t have to wait until MedtecLIVE 2024 in Stuttgart to get to know velixX GmbH!
At velixX, our experienced engineers bring their expertise and professional knowledge to successfully implement your ideas. We offer customized solutions and individual consulting for your specific challenges. Through our large network of experts, your ideas can thrive and grow with us.
Our dedicated project managers are ready to drive your development and create customized solutions for you. You can count on us to thoroughly understand your requirements and achieve your goals.
If you are wondering how you can benefit from our expertise and services, please do not hesitate to contact us anytime at mail@velixx.com.
We are always ready for networking in medical technology and perfect healthcare solutions – and we look forward to hearing from you and developing innovative solutions together!
Wir sind stets bereit für Networking in der Medizintechnik und perfekte Gesundheitslösungen – und wir freuen uns darauf, von Ihnen zu hören und gemeinsam innovative Lösungen zu entwickeln!
Since August 2019, velixX GmbH’s quality management system has been certified according to the latest ISO standard for medical technology development – and has now been newly recertified in August 2022.
During the recertification audit, which took place on August 11th and 12th, the QM system of velixX GmbH was again certified as meeting all requirements of the standard.
“Quality management is a matter of course in medical technology – and for us at velixX it was clear that we would also have our quality management system certified,” emphasizes Managing Director Manfred Augstein. “Quality management does not depend on the size of the company – and we are pleased that we have once again been formally certified as working with medical technology-compliant processes.”
There is no conflict between the organization and the management of modern development processes and good quality management. On the contrary. For the customers of velixX GmbH, the QM certificate is further proof of the reliability and the high quality of results of the services offered.
“Our customers rely not only on our know-how and creative approach to problem solving but also on the reliability and high quality of all our services.”
Long awaited. Exciting from start to finish. And already successful!
It has only been a month since MedtecLIVE in Stuttgart, but the first impression after quite an exhausting week has already been confirmed for velixX.
Almost the entire team was on site. All our engineers were directly approachable and accordingly, many in-depth conversations were possibly. What caused astonishment among some of our new contacts is a matter of course for us:
We are a small team in a highly specialized industry and offer very individual and complex services. Direct communication without long detours is crucial for us. Not only in an initial conversation, but throughout the entire development process.
We are delighted with the great interest shown in us and the numerous new contacts we were able to make in Stuttgart. But we are just as happy about the personal reunions with current and former customers and partners.
See you again in Nuremberg for MedtecLIVE 2023!
Video: © NürnbergMesse GmbH – thank you!
We have had to go withtout trade fairs and conferences for far too long and thus without personal meetings. Now things are really kicking off again with MedtecLIVE in Stuttgart.
Would you like to visit us at booth 10-337? Then contact us for tickets and to make an appointment at mail@velixx.com.
In the meantime, you can read an interview with our CEO Manfred Augstein on the occasion of MedtecLIVE here:
MedtecLIVE with T4M: velixX GmbH is a development company of the “next generation” in medical technology – what does that mean and which topics are relevant?
Manfred Augstein: We are management consultants, technology consultants, and also technology developers. We advise on questions of technical feasibility, business plans and also on basic market positioning. One particular point of focus is regulatory affairs concerning the new IVDR or the MDR. In the process, customers are advised and supported so that they get everything they need on the table. In addition, sustainability also plays a role: how to minimise waste and reduce the carbon footprint in new products, e.g. by using alternative materials or through miniaturisation – we actively support this process.
MedtecLIVE with T4M: Who are your customers? Start-ups, global players or medium-sized companies?
Manfred Augstein: We cover a broad spectrum, from start-ups to multinationals. We do initial consultations on technical implementability, check feasibility, develop products, even for global players who need support in certain niches. But we always focus on where the biggest technical problems or challenges can be found.
MedtecLIVE with T4M: velixX GmbH is a management consultant, technology consultant and technology developer. What does that involve?
Manfred Augstein: Yes, there is a quite a bit involved, and it is hardly possible to fulfil all this as a single company. We see ourselves more as a spider in a web. Our own focus is on microsystems and microfluidic parts. For everything that goes beyond that, we have a large network of competent partners who can, for example, implement serial production or develop software. With this network, we can quickly bring together very flexible teams. We do a system analysis, a problem analysis and offer an optimised solution concept.
MedtecLIVE with T4M: What does such a consulting process look like?
Manfred Augstein: The typical case is like a project we have just started. The company has a few inventors who have taken out a patent on paper for an idea. They then come to us and say: ‘Can you take a look at whether this is even possible?’ And then the project starts with a requirements analysis: ‘what should the product be able to do, what are the general conditions and so on’. Then the functional structure is analysed, followed by one or two workshops to analyse the critical points. A technical analysis follows; is there already data, what needs to be done next? This is followed by detailed planning of the steps needed to find the best solution.
That leaves us with concepts for prototypes which are implemented with the appropriate partners in the network. In working with us, customers can easily scale how comprehensively we take care of the project. They can leave it entirely in our hands and say I only want to see the end product, or they can hand over partial tasks to us. That is very flexible and very individual. Sometimes even large corporations come to us with a product that is almost finished but still needs some fine-tuning. Other customers say, ‘Here’s our idea, our wish, go for it’. We always focus on what the customer wants or needs.
MedtecLIVE with T4M: Why medical technology? What makes this sector so exciting for management consultants?
Manfred Augstein: This industry is the most exciting of all because it really does bring immense benefits to people and without technology, modern medicine would be unthinkable. On the other hand, it is super exciting technologically, because many disciplines come together: medicine, biochemical processes, organic and medical materials, optics, and microsystem solutions. Many elements have to merge, which makes the systemic interfaces in particular very challenging – that’s exactly where we advise.
MedtecLIVE with T4M: What makes your company unique?
Manfred Augstein: The fact that with our small team we can tackle complexities for which other companies need very large and complex organisations. We have broad knowledge, consulting skills, and competent partners. We prefer to work on projects with many functions in the smallest dimensions – that is our speciality. We take very different perspectives, work efficiently, have open, good people who are also wired to think creatively and in a complex way. That is a learning from my many years of professional experience.
MedtecLIVE with T4M: What is the benefit for society?
Manfred Augstein: As a rule, the products we develop help with faster or better diagnosis, especially in our focus area, point-of-care diagnostics. We want to increase reliability and quality, and this is always linked to the goal of producing less waste, making parts smaller and developing more sustainable products.
MedtecLIVE with T4M: What about the market – how will it develop?
Manfred Augstein: There is a lot of potential in this market because medical technology is developing rapidly. The last two years in particular have shown that we have to become even more agile and much faster in order to be able to deal with something like pandemics more efficiently. But most of the time we face more legal problems than technical ones. There is also a need to catch up, for example in digitalisation or in optimising the interfaces between diagnosis and therapy. We have just come through a period in which we had to wait a year until sufficient COVID-19 rapid tests were available. We can’t let something like that happen again.
MedtecLIVE with T4M: One last question: What is your favourite project?
Manfred Augstein: My favourite projects concern the miniaturisation and acceleration of rapid diagnostics. We have a project right now to quickly detect methanol poisoning. This is given far too little focus in the world: the ability to help quickly on the spot, with little effort. Sure, it could be that this also requires a novel approach. But that’s what makes it my favourite project right now.
All this is hardly conceivable without disposables. And that is exactly why it is so important for us at velixX to push this area of medical technology.
We are all familiar with the mountains of rapid tests that are currently being created all over the world. This has shown how important our focus on sustainability is where disposables are concerned. From the planning stages to the final disposal.
We use our customers’ new ideas as a starting point for development: from requirements to technical feasibility to an initial serial production.
Because the members of our team bring a wide range of experience from different disciplines to the table, it is not difficult for us to understand even complex interdependencies and interactions down to the last detail.
Combining many functions in the smallest dimensions is one of our strengths. And is, of course, also a good way to reduce material use and waste.
What does that look like? From the microfluidic cartridge to the complete lab-on-chip – many functions can be combined in very small plastic parts.
Does your task require a complex solution in a very small space? Then you have come to the right place.
We freely admit it: we’ve missed the personal encounters. Even though our industry in particular has had more important things to do in the past two years than attend trade shows.
In addition, the existing networks and collaborations in medical technology have played a major role in ensuring that, even without face-to-face meetings, diagnostic procedures and therapeutic approaches have been developed and advanced at high speed to help cope with the pandemic.
We would like to take this opportunity to thank our colleagues in the industry for their efforts. They have all worked under difficult conditions, doing overtime around the clock, and certainly not just “doing their job.”
Some things have been left undone in the past two years. But in other areas, one milestone after the other has been achieved under high pressure. And we have all learned a lot.
We at velixX are pleased that we now have the opportunity at MEDICA and COMPAMED 2021 in Düsseldorf to once again enter into creative exchange not only with the many existing partners and customers, but also with the entire industry.
If you have a new idea or need new input for an existing project – if you are looking for a sounding board or advice on the best cooperation partners:
Contact us – preferably at mail@velixx.com – and make an appointment to meet us at MEDICA or COMPAMED.
Let’s continue with the multimedia insight into our medical device development: We develop medical technology and in-vitro diagnostics products in collaboration with highly innovative customers. We find solutions for all kinds of technical challenges.
Since August 2019 our quality management system is certified according to the latest ISO standard for medical device development.
The mdc medical device certification GmbH confirms, that the QM-System from velixX corresponds to ISO 13485:2016 standard in all points.
Just in time before the 9th anniversary of the company’s foundation, the quality management system of velixX GmbH was certified according to ISO 13485:2016.
During the certification audit carried out on 22/23 July 2019, the velixX QM system was certified to meet all requirements of the standard. The audit report certified that all processes fully comply with the requirements of the standard without any deviation.
Based on this, the certification committee of mdc medical device certification GmbH issued the certificate to velixX GmbH.
velixX is very proud to be able to show that quality management does not depend on the size of the company and that the company has thus also been formally certified to work with medical technology-compliant processes.
The organization and management of modern development processes do not contradict good quality management.
For the customers of velixX, this is a further proof of the reliability and high result quality of the services offered.